PKN2 and cancer: To validate our observations in human cancer data, we defined a PKN2-null matrisome signature of statistically significant DE genes from PSCs (Table S1), which concurred with expression in orthotopic tumors (Table S2); we selected the top 11 genes as a high-confidence PKN2KO matrisome gene set (Figure 6D; Table S3).